The DOI matches its Crossref record; 90 of the 90 references it cites were found in a registry or an index.
IVIG-mediated effector functions in autoimmune and inflammatory diseases
Open accessAbstract
Intravenous immunoglobulin (IVIG) is a pooled preparation of normal IgG obtained from several thousand healthy donors. It is widely used in the immunotherapy of a large number of autoimmune and inflammatory diseases. The mechanisms of action of IVIG are complex and, as discussed in this review, experimental and clinical data provide an indicator that the therapeutic benefit of IVIG therapy is due to several mutually non-exclusive mechanisms affecting soluble mediators as well as cellular components of the immune system. These mechanisms depend on Fc and/or F(ab′)2 fragments. A better understanding of the effector functions of IVIG should help in identification of biomarkers of responses to IVIG in autoimmune patients.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Fcγ receptors as regulators of immune responses
Nimmerjahn, F., & Ravetch, J. V. (2008) · Nature Reviews Immunology · doi:10.1038/nri2206 · Cited by 2,947 · cited 2×
“cytoplasmic domain of a single α-chain (1, 2).”
BackgroundAnti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation
Kaneko, Y., Nimmerjahn, F., & Ravetch, J. V. (2006) · Science · doi:10.1126/science.1129594 · Cited by 1,754
Immunomodulation of Autoimmune and Inflammatory Diseases with Intravenous Immune Globulin
Kazatchkine, M. D., & Kaveri, S. V. (2001) · New England Journal of Medicine · doi:10.1056/nejmra993360 · Cited by 1,209
Self-citationAnti-inflammatory Activity of IVIG Mediated Through the Inhibitory Fc Receptor
Samuelsson, A., Towers, T. L., & Ravetch, J. V. (2001) · Science · doi:10.1126/science.291.5503.484 · Cited by 1,053
Recapitulation of IVIG anti-inflammatory activity with a recombinant IgG Fc
Anthony, R. M., Nimmerjahn, F., Ashline, D. J., Reinhold, V. N., Paulson, J. C., & Ravetch, J. V. (2008) · Science · doi:10.1126/science.1154315 · Cited by 849 · cited 1×
“The sialylated fraction accounted for nearly 10% of IgG; recombinant Fc fragments containing terminal α2,6-sialic acid linkages and IVIG with controlled tetra-Fc sialylation could also recapitulate IVIG actions (26, 27).”
BackgroundJunghans, R. P., & Anderson, C. L. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.11.5512 · Cited by 684
Intravenous gammaglobulin suppresses inflammation through a novel TH2 pathway
Anthony, R. M., Kobayashi, T., Wermeling, F., & Ravetch, J. V. (2011) · Nature · doi:10.1038/nature10134 · Cited by 633
Mouse and human FcR effector functions
Bruhns, P., & Jönsson, F. (2015) · Immunological Reviews · doi:10.1111/imr.12350 · Cited by 579
Identification of a receptor required for the anti-inflammatory activity of IVIG
Anthony, R. M., Wermeling, F., Karlsson, M. C. I., & Ravetch, J. V. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0810163105 · Cited by 547
Intravenous Immune Globulin in Autoimmune and Inflammatory Diseases
Gelfand, E. W. (2012) · New England Journal of Medicine · doi:10.1056/nejmra1009433 · Cited by 495
Basta, M., & Dalakas, M. C. (1994) · Journal of Clinical Investigation · doi:10.1172/jci117520 · Cited by 396
Activation of natural regulatory T cells by IgG Fc–derived peptide “Tregitopes”
De Groot, A. S., Moise, L., McMurry, J. A., Wambre, E., Van Overtvelt, L., Moingeon, P., Scott, D. W., & Martin, W. (2008) · Blood · doi:10.1182/blood-2008-02-138073 · Cited by 392
Treatment of Refractory Immune Thrombocytopenic Purpura with an Anti-Fcγ-Receptor Antibody
Clarkson, S. B., Bussel, J. B., Kimberly, R. P., Valinsky, J. E., Nachman, R. L., & Unkeless, J. C. (1986) · New England Journal of Medicine · doi:10.1056/nejm198605083141907 · Cited by 365
Infusion of Fcγ fragments for treatment of children with acute immune thrombocytopenic purpura
Debré, M., Griscelli, C., Bonnet, M.-C., Carosella, E., Philippe, N., Reinert, P., Vilmer, E., Kaplan, C., Fridman, W. H., & Teillaud, J.-L. (1993) · The Lancet · doi:10.1016/0140-6736(93)92000-j · Cited by 329
Inhibition of maturation and function of dendritic cells by intravenous immunoglobulin
Bayry, J., Lacroix-Desmazes, S., Carbonneil, C., Misra, N., Donkova, V., Pashov, A., Chevailler, A., Mouthon, L., Weill, B., Bruneval, P., et al. (2003) · Blood · doi:10.1182/blood-2002-05-1447 · Cited by 306
Self-citationBruhns, P., Samuelsson, A., Pollard, J. W., & Ravetch, J. V. (2003) · Immunity · doi:10.1016/s1074-7613(03)00080-3 · Cited by 304
Intravenous immunoglobulin in neurology—mode of action and clinical efficacy
Lünemann, J. D., Nimmerjahn, F., & Dalakas, M. C. (2015) · Nature Reviews Neurology · doi:10.1038/nrneurol.2014.253 · Cited by 301
Ephrem, A., Chamat, S., Miquel, C., Fisson, S., Mouthon, L., Caligiuri, G., Delignat, S., Elluru, S., Bayry, J., Lacroix-Desmazes, S., et al. (2008) · Blood · doi:10.1182/blood-2007-03-079947 · Cited by 292
Self-citationPrasad, N. K. A., Papoff, G., Zeuner, A., Bonnin, E., Kazatchkine, M. D., Ruberti, G., & Kaveri, S. V. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.161.7.3781 · Cited by 279
Self-citationComplete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases
Li, N. (2005) · Journal of Clinical Investigation · doi:10.1172/jci24394 · Cited by 264
Intravenous immunoglobulin ameliorates ITP via activating Fcγ receptors on dendritic cells
Siragam, V., Crow, A. R., Brinc, D., Song, S., Freedman, J., & Lazarus, A. H. (2006) · Nature Medicine · doi:10.1038/nm1416 · Cited by 246
Kessel, A., Ammuri, H., Peri, R., Pavlotzky, E. R., Blank, M., Shoenfeld, Y., & Toubi, E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.179.8.5571 · Cited by 234
Washburn, N., Schwab, I., Ortiz, D., Bhatnagar, N., Lansing, J. C., Medeiros, A., Tyler, S., Mekala, D., Cochran, E., Sarvaiya, H., et al. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1422481112 · Cited by 225
Arumugam, T. V., Tang, S.-C., Lathia, J. D., Cheng, A., Mughal, M. R., Chigurupati, S., Magnus, T., Chan, S. L., Jo, D.-G., Ouyang, X., et al. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0700506104 · Cited by 204
The MHC class I–like Fc receptor promotes humorally mediated autoimmune disease
Akilesh, S., Petkova, S., Sproule, T. J., Shaffer, D. J., Christianson, G. J., & Roopenian, D. (2004) · Journal of Clinical Investigation · doi:10.1172/jci18838 · Cited by 196
Trinath, J., Hegde, P., Sharma, M., Maddur, M. S., Rabin, M., Vallat, J.-M., Magy, L., Balaji, K. N., Kaveri, S. V., & Bayry, J. (2013) · Blood · doi:10.1182/blood-2012-11-468264 · Cited by 164
Self-citationMassoud, A. H., Yona, M., Xue, D., Chouiali, F., Alturaihi, H., Ablona, A., Mourad, W. M., Piccirillo, C. A., & Mazer, B. D. (2013) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2013.09.029 · Cited by 161
Raju, R., & Dalakas, M. C. (2005) · Brain · doi:10.1093/brain/awh518 · Cited by 160
Guo, M. M., Tseng, W., Ko, C. ‐., Pan, H.-Y., Hsieh, K., & Kuo, H. (2014) · Allergy · doi:10.1111/all.12558 · Cited by 158
Park-Min, K.-H., Serbina, N. V., Yang, W., Ma, X., Krystal, G., Neel, B. G., Nutt, S. L., Hu, X., & Ivashkiv, L. B. (2007) · Immunity · doi:10.1016/j.immuni.2006.11.010 · Cited by 158
Maddur, M. S., Vani, J., Hegde, P., Lacroix‐Desmazes, S., Kaveri, S. V., & Bayry, J. (2011) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2010.12.1102 · Cited by 156
Self-citationIVIg modulates BCR signaling through CD22 and promotes apoptosis in mature human B lymphocytes
Séïté, J.-F., Cornec, D., Renaudineau, Y., Youinou, P., Mageed, R. A., & Hillion, S. (2010) · Blood · doi:10.1182/blood-2009-12-261461 · Cited by 154
An open-label study of high-dose intravenous immunoglobulin in severe childhood asthma
Mazer, B. D., & Gelfand, E. W. (1991) · Journal of Allergy and Clinical Immunology · doi:10.1016/0091-6749(91)90420-s · Cited by 149
Intravenous immunoglobulin therapy in rheumatic diseases
Bayry, J., Negi, V. S., & Kaveri, S. V. (2011) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2011.61 · Cited by 145
Self-citationCampbell, I. K., Miescher, S., Branch, D. R., Mott, P. J., Lazarus, A. H., Han, D., Maraskovsky, E., Zuercher, A. W., Neschadim, A., Leontyev, D., et al. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301611 · Cited by 140
von Gunten, S., Schaub, A., Vogel, M. T., Stadler, B. M., Miescher, S., & Simon, H. (2006) · Blood · doi:10.1182/blood-2006-05-021568 · Cited by 139
Yu, X., Vasiljević, S., Mitchell, D. A., Crispin, M., & Scanlan, C. N. (2013) · Journal of Molecular Biology · doi:10.1016/j.jmb.2013.02.006 · Cited by 130
Schwab, I., Mihai, S., Seeling, M., Kasperkiewicz, M., Ludwig, R. J., & Nimmerjahn, F. (2014) · European Journal of Immunology · doi:10.1002/eji.201344230 · Cited by 129
Käsermann, F., Boerema, D. J., Monika, R., Hofmann, A., Wymann, S., Zuercher, A. W., & Miescher, S. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037243 · Cited by 127
Aslam, R., Hu, Y., Gebremeskel, S., Segel, G. B., Speck, E. R., Guo, L., Kim, M. S., Ni, H., Freedman, J. J., & Semple, J. W. (2012) · Blood · doi:10.1182/blood-2012-02-413526 · Cited by 125
Binding of cytokines to pharmaceutically prepared human immunoglobulin.
Svenson, M., Hansen, M. B., & Bendtzen, K. (1993) · Journal of Clinical Investigation · doi:10.1172/jci116862 · Cited by 124
Leontyev, D., Katsman, Y., Ma, X., Miescher, S., Käsermann, F., & Branch, D. R. (2012) · Transfusion · doi:10.1111/j.1537-2995.2011.03517.x · Cited by 119
de Souza, V. R., Carreno, M., Kaveri, S. V., Ledur, A., Sadeghi, H. M., Cavaillon, J., Kazatchkine, M. D., & Haeffner‐Cavaillon, N. (1995) · European Journal of Immunology · doi:10.1002/eji.1830250521 · Cited by 118
Self-citationNagelkerke, S. Q., Dekkers, G., Kustiawan, I., van de Bovenkamp, F. S., Geissler, J., Plomp, R., Wuhrer, M., Vidarsson, G., Rispens, T., van den Berg, T. K., et al. (2014) · Blood · doi:10.1182/blood-2014-05-576835 · Cited by 114
Fiebiger, B. M., Maamary, J., Pincetic, A., & Ravetch, J. V. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505292112 · Cited by 113
Guhr, T., Bloem, J., Derksen, N. I. L., Wuhrer, M., Koenderman, A. H. L., Aalberse, R. C., & Rispens, T. (2011) · PLoS ONE · doi:10.1371/journal.pone.0021246 · Cited by 113
Chen, P., Li, C., Lang, S., Zhu, G., Adili, R., Spring, C. M., Freedman, J. J., & Ni, H. (2010) · Blood · doi:10.1182/blood-2010-05-284919 · Cited by 112
Damås, J. K., Gullestad, L. L., Aass, H., Simonsen, S., Fjeld, J. G., Wikeby, L., Ueland, T., Eiken, H. G., Frøland, S. S., & Aukrust, P. (2001) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(01)01335-3 · Cited by 108
Intravenous immunoglobulin preparations contain anti–Siglec-8 autoantibodies
von Gunten, S., Vogel, M. T., Schaub, A., Stadler, B. M., Miescher, S., Crocker, P. R., & Simon, H. (2007) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2007.01.023 · Cited by 107
Ruiz, J. E., Kwak, J. Y. H., Baum, L. L., Gilman‐Sachs, A., Beaman, K. D., Kim, Y. B., & Beer, A. E. (1996) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1996.tb00496.x · Cited by 104
Intravenous immunoglobulin as clinical immune-modulating therapy
Gilardin, L., Bayry, J., & Kaveri, S. V. (2015) · Canadian Medical Association Journal · doi:10.1503/cmaj.130375 · Cited by 103
Self-citationChang, J., Shi, P. A., Chiang, E. Y., & Frenette, P. S. (2007) · Blood · doi:10.1182/blood-2007-04-084061 · Cited by 101
Perricone, R., Muzio, G. D., Perricone, C., Giacomelli, R., Nardo, D. D., Fontana, L., & Carolis, C. D. (2006) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.2005.00356.x · Cited by 92
IgG1 and IVIg induce inhibitory ITAM signaling through FcγRIII controlling inflammatory responses
Aloulou, M., Mkaddem, S. B., Biarnes‐Pelicot, M., Boussetta, T., Souchet, H., Rossato, E., Benhamou, M., Crestani, B., Zhu, Z., Blank, U., et al. (2012) · Blood · doi:10.1182/blood-2011-08-376046 · Cited by 92
Tha‐In, T., Metselaar, H. J., Tilanus, H. W., Groothuismink, Z. M. A., Kuipers, E. J., de Man, R. A., & Kwekkeboom, J. (2007) · Blood · doi:10.1182/blood-2007-03-077057 · Cited by 84
Bayry, J., Bansal, K., Kazatchkine, M. D., & Kaveri, S. V. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900016106 · Cited by 81
Self-citationde Grandmont, M. J., Racine, C., Roy, A., Lemieux, R., & Néron, S. (2003) · Blood · doi:10.1182/blood-2002-06-1684 · Cited by 79
IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist
von Gunten, S., Shoenfeld, Y., Blank, M., Branch, D. R., Vassilev, T. L., Käsermann, F., Bayry, J., Kaveri, S. V., & Simon, H. (2014) · Nature reviews. Immunology · doi:10.1038/nri3401-c1 · Cited by 76
Self-citationOthy, S., Hegde, P., Topçu, S., Sharma, M., Maddur, M. S., Lacroix‐Desmazes, S., Bayry, J., & Kaveri, S. V. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201965 · Cited by 73
Self-citationBAFF, a New Target for Intravenous Immunoglobulin in Autoimmunity and Cancer
Pottier, L. L., Bendaoud, B., Dueymes, M., Daridon, C., Youinou, P., Shoenfeld, Y., & Pers, J. (2007) · Journal of Clinical Immunology · doi:10.1007/s10875-007-9082-2 · Cited by 72
Ogata, S., Shimizu, C., Franco, A., Touma, R., Kanegaye, J. T., Choudhury, B., Naidu, N., Kanda, Y., Hoang, L. T., Hibberd, M. L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0081448 · Cited by 71
Massoud, A. H., Guay, J., Shalaby, K. H., Bjur, E., Ablona, A., Chan, D., Nouhi, Y., McCusker, C. T., Mourad, W. M., Piccirillo, C. A., et al. (2012) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2012.02.050 · Cited by 70
Maddur, M. S., Rabin, M., Hegde, P., Bolgert, F., Guy, M., Vallat, J., Magy, L., Bayry, J., & Kaveri, S. V. (2014) · Immunologic Research · doi:10.1007/s12026-014-8580-6 · Cited by 69
Self-citationWIEDEMAN, A. E., Santer, D. M., Yan, W., Miescher, S., Käsermann, F., & Elkon, K. B. (2013) · Arthritis & Rheumatism · doi:10.1002/art.38082 · Cited by 66
Comparison of different IVIg preparations on IL-17 production by human Th17 cells
Maddur, M. S., Kaveri, S. V., & Bayry, J. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.02.007 · Cited by 65
Self-citationTjon, A. S. W., van Gent, R., Jaadar, H., van Hagen, P. M., Mancham, S., van der Laan, L. J. W., Boekhorst, P. A. W. T., Metselaar, H. J., & Kwekkeboom, J. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1301260 · Cited by 63
Predisposing factors, pathogenesis and therapeutic intervention of Kawasaki disease
Galeotti, C., Kaveri, S. V., Cimaz, R., Koné‐Paut, I., & Bayry, J. (2016) · Drug Discovery Today · doi:10.1016/j.drudis.2016.08.004 · Cited by 63
Self-citationFcγ receptor expression on splenic macrophages in adult immune thrombocytopenia
Audia, S., Santegoets, K. C. M., Laarhoven, A. G., Vidarsson, G., Facy, O., Ortega‐Deballon, P., Samson, M., Janikashvili, N., Saas, P., Bonnotte, B., et al. (2017) · Clinical & Experimental Immunology · doi:10.1111/cei.12935 · Cited by 63
Kozicky, L. K., Zhao, Z., Menzies, S. C., Fidanza, M., Reid, G. S. D., Wilhelmsen, K., Hellman, J., Hotte, N., Madsen, K. L., & Sly, L. M. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.3vma0315-078r · Cited by 57
Othy, S., Topçu, S., Saha, C., Kothapalli, P., Lacroix‐Desmazes, S., Käsermann, F., Miescher, S., Bayry, J., & Kaveri, S. V. (2014) · European Journal of Immunology · doi:10.1002/eji.201444440 · Cited by 55
Self-citationIncreased nitric oxide production by neutrophils in early stage of Kawasaki disease
Yoshimura, K., Tatsumi, K., Iharada, A., Tsuji, S., Tateiwa, A., Teraguchi, M., Ogino, H., & Kaneko, K. (2008) · European Journal of Pediatrics · doi:10.1007/s00431-008-0872-1 · Cited by 49
IVIg Attenuates TLR-9 Activation in B Cells from SLE Patients
Kessel, A., Peri, R., Haj, T., Snir, A., Slobodin, G., Sabo, E., Rosner, I., Shoenfeld, Y., & Toubi, E. (2010) · Journal of Clinical Immunology · doi:10.1007/s10875-010-9469-3 · Cited by 48
Séïté, J.-F., Guerrier, T., Cornec, D., Jamin, C., Youinou, P., & Hillion, S. (2011) · Journal of Autoimmunity · doi:10.1016/j.jaut.2011.05.014 · Cited by 48
Jang, J.-E., Hidalgo, A., & Frenette, P. S. (2012) · Circulation Research · doi:10.1161/circresaha.112.266411 · Cited by 48
Schwab, I., Lux, A., & Nimmerjahn, F. (2015) · Cell Reports · doi:10.1016/j.celrep.2015.09.013 · Cited by 47
Crow, A. R., Suppa, S. J., Chen, X., Mott, P. J., & Lazarus, A. H. (2011) · Blood · doi:10.1182/blood-2011-08-374223 · Cited by 44
Sharma, M., Schoindre, Y., Hegde, P., Saha, C., Maddur, M. S., Victor, E. S., Gilardin, L., Lecerf, M., Bruneval, P., Mouthon, L., et al. (2014) · Scientific Reports · doi:10.1038/srep05672 · Cited by 43
Self-citationCasulli, S., Topçu, S., Fattoum, L., von Gunten, S., Simon, H., Teillaud, J., Bayry, J., Kaveri, S. V., & Elbim, C. (2011) · PLoS ONE · doi:10.1371/journal.pone.0026469 · Cited by 43
Self-citationLee, S.-Y., Jung, Y., Ryu, J., Kang, C., Kim, E., Son, H., Yang, E., Ju, J., Kang, Y., Park, S., et al. (2014) · Arthritis & Rheumatology · doi:10.1002/art.38627 · Cited by 43
Sehgal, K., Guo, X., Koduru, S. V., Shah, A., Lin, A., Yan, X., & Dhodapkar, K. M. (2013) · Science Translational Medicine · doi:10.1126/scitranslmed.3006277 · Cited by 40
Maddur, M. S., Trinath, J., Rabin, M., Bolgert, F., Guy, M., Vallat, J., Magy, L., Balaji, K. N., Kaveri, S. V., & Bayry, J. (2014) · Cellular and Molecular Immunology · doi:10.1038/cmi.2014.117 · Cited by 39
Self-citationMurakami, K., Suzuki, C., Kobayashi, F., Nakano, A., Fujii, A., Sakai, K., & Imada, T. (2012) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-012-0765-8 · Cited by 35
Maddur, M. S., Victor, E. S., Das, M., Prakhar, P., Sharma, V. K., Singh, V., Rabin, M., Trinath, J., Balaji, K. N., Bolgert, F., et al. (2017) · Journal of Neuroinflammation · doi:10.1186/s12974-017-0818-5 · Cited by 35
Self-citationSaha, C., Das, M., Patil, V., Victor, E. S., Sharma, M., Wymann, S., Jordi, M., Vonarburg, C., Kaveri, S. V., & Bayry, J. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00275 · Cited by 32
Self-citationB cells are resistant to immunomodulation by ‘IVIg-educated’ dendritic cells
Maddur, M. S., Hegde, P., Sharma, M., Kaveri, S. V., & Bayry, J. (2011) · Autoimmunity Reviews · doi:10.1016/j.autrev.2011.08.004 · Cited by 27
Self-citationHeme oxygenase-1 is dispensable for the anti-inflammatory activity of intravenous immunoglobulin
Galeotti, C., Hegde, P., Das, M., Victor, E. S., Canale, F. P., Munoz, M. D., Sharma, V. K., Dimitrov, J. D., Kaveri, S. V., & Bayry, J. (2016) · Scientific Reports · doi:10.1038/srep19592 · Cited by 27
Self-citationOthy, S., Bruneval, P., Topçu, S., Dugail, I., Delers, F., Lacroix‐Desmazes, S., Bayry, J., & Kaveri, S. V. (2012) · Journal of Autoimmunity · doi:10.1016/j.jaut.2012.05.013 · Cited by 26
Self-citationSudo, M., Yamaguchi, Y., Späth, P., Morita‐Matsumoto, K., Ong, B. K. C., Shahrizaila, N., & Yuki, N. (2014) · PLoS ONE · doi:10.1371/journal.pone.0107772 · Cited by 24
Gene expression profiling of the effects of intravenous immunoglobulin in human whole blood
Ghielmetti, M., Bellis, M., Spycher, M. O., Miescher, S., & Vergères, G. (2005) · Molecular Immunology · doi:10.1016/j.molimm.2005.06.024 · Cited by 18
Idiotypic and anti-idiotypic elastin autoantibodies: Implications for IVIg and pregnancy loss
Konova, E. I., Atanasova, M., Stoykov, S., Velkova, A. S., & Shoenfeld, Y. (2006) · Journal of Autoimmunity · doi:10.1016/j.jaut.2006.11.002 · Cited by 17
Cited by
COVID-19: Transmission, prevention, and potential therapeutic opportunities
Lotfi, M., Hamblin, M. R., & Rezaei, N. (2020) · Clinica Chimica Acta · doi:10.1016/j.cca.2020.05.044 · Cited by 1,016
Implications of macrophage polarization in autoimmunity
Funes, S. C., Rios, M., Escobar‐Vera, J., & Kalergis, A. M. (2018) · Immunology · doi:10.1111/imm.12910 · Cited by 1,005
A perspective on potential antibody-dependent enhancement of SARS-CoV-2
Arvin, A. M., Fink, K., Schmid, M. A., Cathcart, A., Spreafico, R., Havenar-Daughton, C., Lanzavecchia, A., Corti, D., & Virgin, H. W. (2020) · Nature · doi:10.1038/s41586-020-2538-8 · Cited by 485
Cao, W., Liu, X., Bai, T., Fan, H., Hong, K., Song, H., Han, Y., Lin, L., Ruan, L., & Li, T. (2020) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaa102 · Cited by 405
Pharmaco-Immunomodulatory Therapy in COVID-19
Rizk, J. G., Kalantar-Zadeh, K., Mehra, M. R., Lavie, C. J., Rizk, Y., & Forthal, D. N. (2020) · Drugs · doi:10.1007/s40265-020-01367-z · Cited by 288
Metadata
- Authors
- Galeotti, C., Kaveri, S. V., & Bayry, J.
- Venue
- International Immunology
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-07-20
- Volume
- 29
- Issue
- 11
- Pages
- 491-498
- ISSN
- 0953-8178 (ISSN-L)
- 1460-2377
- OpenAlex
- W2726030955
- Cited by
- 269
- References
- 90
- FWCI
- 19.31
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.